Ametek
AME
$237.13
-1.99%
Ametek, Inc. is a diversified industrial manufacturer operating through two primary segments: the Electronic Instruments Group (EIG), which provides analytical, test, and measurement instruments, and the Electromechanical Group (EMG), which produces highly engineered components, interconnects, and specialty metals. The company is a market leader in numerous niche industrial markets, distinguished by its decentralized operating model of over 40 autonomous businesses and a long-term strategy focused on product differentiation and strategic acquisitions. The current investor narrative centers on the company's ability to sustain growth and margin expansion through its proven acquisition engine and operational discipline, a theme reinforced by recent news of a 10% dividend increase signaling management's confidence in its financial health and future cash flow generation.…
AME
Ametek
$237.13
Related headlines
Investment Opinion: Should I buy AME Today?
Rating & Thesis: Hold. AME is a high-quality industrial compounder with exceptional fundamentals, but its premium valuation fully reflects this quality, leaving limited near-term margin of safety and elevated risk of multiple compression. The implied analyst consensus suggests a modest 12.6% upside, which may not adequately compensate for the valuation risk in the current environment.
Supporting Evidence: The recommendation is grounded in four specific data points: 1) The forward PE of 27.00x is a ~35-50% premium to many industrial peers, 2) Revenue growth remains strong at 13.44% YoY, 3) Profitability is stellar with a net margin of 19.95%, and 4) Free cash flow generation of $1.67B supports the dividend and growth strategy. However, the PEG ratio of 4.05 signals expensive growth, and the stock trades at 97% of its 52-week high, suggesting much optimism is already priced in.
Risks & Conditions: The two biggest risks are valuation compression and growth deceleration. This Hold rating would upgrade to a Buy if the forward PE compresses to the low-20s (offering a better entry point) or if revenue growth accelerates sustainably above 15% YoY. It would downgrade to a Sell if quarterly revenue growth decelerates below 10% or if operating margins show sustained contraction. Relative to its own history and peer group, the stock is currently overvalued, trading at the upper end of its historical multiple range.
Sign up to view all
AME 12-Month Price Forecast
AME is a textbook example of a high-quality company at a full price. The fundamentals are undeniably strong, with excellent growth, profitability, and financial health. However, the investment case at current levels is balanced. The stock's premium valuation leaves little room for error and makes it vulnerable to shifts in market sentiment. The neutral stance reflects the view that the probable 12-month outcome is modest single-digit returns (base case), with the potential for a better buying opportunity if the multiple contracts. The stance would turn bullish on a pullback to a forward PE near 24x or bearish on a breakdown of the $220 support level on deteriorating fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ametek's 12-month outlook, with a consensus price target around $308.27 and implied upside of +30.0% versus the current price.
Average Target
$308.27
7 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
7
covering this stock
Price Range
$190 - $308
Analyst target range
Analyst coverage for Ametek is moderate with 7 analysts providing estimates, and the institutional ratings show a mix of bullish and neutral stances, including recent actions like BMO Capital maintaining an 'Outperform' and Morgan Stanley an 'Equal Weight'. The consensus leans bullish, though the average target price must be inferred from estimated EPS; using the average estimated EPS of $9.91 and the forward PE of 27.00x implies a consensus price target of approximately $267.54, representing a potential upside of about 12.6% from the current price of $237.52. The target range, derived from estimated EPS, spans from a low of $9.63 to a high of $10.29, translating to price targets of roughly $260 to $278 based on the forward multiple, indicating a relatively tight spread that reflects strong conviction in the company's steady performance, with the high target banking on continued execution of the growth-through-acquisition strategy and margin resilience.
Bulls vs Bears: AME Investment Factors
The evidence for AME is nuanced but leans bullish, primarily due to its strong fundamental execution, robust cash flow, and clear growth trajectory. The bear case is almost entirely valuation-driven, hinging on the sustainability of its premium multiples. The single most important tension in the investment debate is whether the company's proven ability to deliver consistent double-digit revenue growth and high margins can justify and sustain a PE multiple that is approximately 50% above typical industrial peers. The resolution of this tension—through either sustained execution or economic moderation—will dictate the stock's direction.
Bullish
- Robust Revenue Growth and Margin Expansion: Q4 2025 revenue grew 13.44% YoY to $1.998B, with sequential quarterly growth from $1.732B in Q1 2025. This is supported by a strong Q4 net margin of 19.95% and operating margin of 26.17%, indicating disciplined execution and pricing power.
- Exceptional Free Cash Flow and Financial Health: Trailing twelve-month free cash flow of $1.671B funds dividends, buybacks, and acquisitions without strain. The conservative balance sheet, with a debt-to-equity ratio of 0.22 and a current ratio of 1.06, provides significant financial flexibility.
- Analyst Consensus Implies ~12.6% Upside: Using the forward EPS estimate of $9.91 and a forward PE of 27.0x, the implied consensus price target is ~$267.54, representing a 12.6% upside from the current price of $237.52. The high-end target of ~$278 suggests further potential on flawless execution.
- Proven Acquisition Engine and Market Leadership: The decentralized model of over 40 autonomous businesses in niche industrial markets, coupled with a 10% dividend increase in February 2026, signals management's confidence in sustained organic growth and the ability to deploy capital accretively.
Bearish
- Premium Valuation at Risk of Compression: The trailing PE of 31.98x and forward PE of 27.00x are at the upper end of the stock's historical range and well above typical industrial multiples. This premium leaves the stock vulnerable to multiple compression if growth decelerates or macro conditions worsen.
- Slowing Momentum and Technical Resistance: While up 32.09% over the past year, the 1-month gain of 4.92% has decelerated from the 3-month gain of 13.52%. The stock faces immediate resistance at the 52-week high of $244.71, and a failure to break through could trigger a pullback toward the $220-$230 support zone.
- High PEG Ratio Suggests Overvaluation for Growth: The PEG ratio of 4.05, based on the trailing PE, indicates the stock's price is high relative to its earnings growth rate. This suggests the market may be overpaying for future growth, increasing downside risk if growth expectations are not met.
- Dependence on Continued Acquisition Success: A significant portion of the growth narrative relies on the successful and accretive integration of acquisitions. Any slowdown in the M&A pipeline, overpayment for assets, or integration issues could materially impact the growth trajectory and investor sentiment.
AME Technical Analysis
The stock is in a sustained uptrend, evidenced by a 32.09% gain over the past year, and is currently trading at approximately 97% of its 52-week high of $244.71, indicating strong momentum but also positioning it near a critical resistance level where further gains may be challenged. Recent momentum shows a 4.92% gain over the past month, which, while positive, has decelerated from the 13.52% gain over the past three months, suggesting the uptrend may be entering a consolidation phase after a significant run-up. Key technical levels are clear, with immediate resistance at the 52-week high of $244.71 and support at the 52-week low of $174.43; a decisive breakout above resistance would signal a continuation of the bull trend, while a failure could lead to a pullback towards the $220-$230 range, especially given the stock's beta of 1.004 indicates market-average volatility, making it susceptible to broader market swings. The price action from the provided data shows a recent pullback from $240.95 to $237.52, a -1.42% single-day move, which aligns with the notion of testing near-term support after approaching the yearly high.
Beta
1.00
1.00x market volatility
Max Drawdown
-13.7%
Largest decline past year
52-Week Range
$174-$245
Price range past year
Annual Return
+29.5%
Cumulative gain past year
| Period | AME Return | S&P 500 |
|---|---|---|
| 1m | +6.2% | -1.7% |
| 3m | +8.6% | +13.7% |
| 6m | +13.4% | +9.2% |
| 1y | +29.5% | +20.7% |
| ytd | +13.4% | +9.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AME Fundamental Analysis
Revenue growth remains robust, with Q4 2025 revenue of $1.998 billion representing a 13.44% year-over-year increase, and sequential quarterly revenue has grown from $1.732 billion in Q1 2025 to the Q4 figure, demonstrating consistent top-line expansion driven by both operating segments, where the Electronic Instruments Group ($1.370 billion) is the larger contributor compared to the Electromechanical Group ($628.9 million). Profitability is strong and margins are healthy, with Q4 2025 net income of $398.6 million and a net margin of 19.95%, supported by a gross margin of 36.93% and an operating margin of 26.17%; these margins have remained stable through recent quarters, with the Q4 gross margin of 36.93% slightly above the Q3 level of 36.25%, indicating disciplined cost control. The balance sheet is conservative and cash flow generation is exemplary, with a low debt-to-equity ratio of 0.22, a current ratio of 1.06 providing ample liquidity, and robust trailing twelve-month free cash flow of $1.671 billion, which comfortably funds the company's dividend, share repurchases, and strategic acquisition strategy without reliance on excessive external financing.
Quarterly Revenue
$2.0B
2025-12
Revenue YoY Growth
+0.13%
YoY Comparison
Gross Margin
+0.36%
Latest Quarter
Free Cash Flow
$1.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AME Overvalued?
Given the consistently positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. Ametek trades at a trailing PE of 31.98x and a forward PE of 27.00x; the lower forward multiple implies the market expects earnings growth, with analysts projecting forward EPS of $9.91. Compared to sector averages, Ametek's valuation commands a significant premium; its trailing PE of 31.98x and forward PE of 27.00x are well above typical industrial multiples, which often range in the low 20s, reflecting the market's payment for the company's superior growth profile, high profitability, and consistent execution. Historically, the current trailing PE of 31.98x is near the upper end of its own range observed in recent quarters, which has fluctuated between approximately 26x and 34x over the past few years, suggesting the stock is pricing in optimistic expectations and may be susceptible to multiple compression if growth moderates.
PE
32.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 22x~34x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AME's primary financial risk is not leverage or liquidity, given its strong balance sheet (D/E 0.22), but rather its valuation dependency on continued high growth. The trailing PE of 31.98x and forward PE of 27.00x require the company to consistently meet or exceed the ~14% revenue growth rate demonstrated in Q4 2025. Any material deceleration, margin contraction from the current ~26% operating margin, or a slowdown in the free cash flow engine ($1.67B TTM) that funds its acquisition strategy could trigger significant multiple compression.
Market & Competitive Risks: The stock trades at a substantial premium to sector averages, making it highly susceptible to valuation compression in a rising interest rate environment or a sector rotation out of industrials. Its market-average beta of 1.004 means it lacks defensive characteristics during broad market downturns. Competitive risks are mitigated by its niche market leadership but are ever-present; disruption in key end-markets like aerospace, energy, or medical could impact demand for its highly engineered instruments and components.
Worst-Case Scenario: The worst-case scenario involves a simultaneous macroeconomic slowdown impacting industrial demand, coupled with a miss on quarterly earnings that breaks the growth narrative. This could lead to rapid de-rating from the current premium multiple toward the lower end of its historical PE range (~26x). A realistic downside could see the stock re-test its 52-week low of $174.43, representing a potential loss of approximately -27% from the current price of $237.52. The bear-case analyst target implied by the low EPS estimate ($9.63) and a compressed multiple points to a similar range near $260, but a break of that level could see a sharper decline toward the $220 support zone initially.
FAQ
The key risks, in order of severity, are: 1) Valuation Risk: The high PE multiple (32x trailing) makes the stock susceptible to a sharp decline if growth moderates or market sentiment sours. 2) Execution Risk: The growth narrative depends on continued successful acquisition integration and organic expansion; a miss here would break the thesis. 3) Macroeconomic Risk: As an industrial with a beta of 1.0, a slowdown in industrial capex or a recession would directly impact demand. 4) Competitive Risk: While it operates in niches, technological disruption or increased competition could pressure its premium pricing and margins over time.
The 12-month forecast presents three scenarios with associated probabilities. The Base Case (60% probability) sees the stock trading between $260 and $275, driven by steady execution and stable valuation multiples. The Bull Case (25% probability) could push the stock to $278-$290 on accelerated growth and multiple expansion. The Bear Case (15% probability) warns of a pullback to $210-$240 on growth deceleration and multiple compression. The most likely outcome is the Base Case, which assumes the company meets current analyst EPS estimates of ~$9.91 and maintains its premium, but not expanding, valuation.
AME is overvalued relative to its industrial sector peers and is at the upper end of its own historical valuation range. The primary metric, the forward Price-to-Earnings (PE) ratio, is 27.0x, which is a significant premium to the sector median, often in the low-20s. Its trailing PE of 32.0x and PEG ratio of 4.05 further indicate the market is paying a high price for its growth. The valuation implies the market expects the company to continue delivering high-teens EPS growth for the foreseeable future without any stumbles. Any deviation from this perfect execution could lead to multiple compression.
For new money at the current price of $237.52, AME is a Hold, not a compelling Buy. While the company is fundamentally excellent with 13.4% revenue growth and a 20% net margin, its valuation is rich at a forward PE of 27.0x, implying only ~12.6% upside to the consensus target. The stock is also trading at 97% of its 52-week high, suggesting limited near-term catalysts. It would be a good buy for a long-term investor on a meaningful pullback (e.g., toward $220) that offers a better risk/reward profile. For existing holders, it remains a solid hold due to its quality.
AME is unequivocally suited for long-term investment (5+ years). Its business model as a decentralized industrial compounder is built for sustained value creation over decades, not quarters. The stock's market-average volatility (beta 1.004) and modest dividend yield (0.6%) make it a poor candidate for short-term trading or income-seeking investors. For a long-term investor willing to tolerate valuation volatility, AME represents a core holding that can compound capital through economic cycles via growth and strategic capital allocation. A minimum holding period of 3-5 years is suggested to allow the company's fundamental strengths to outweigh near-term valuation concerns.